Keros Therapeutics (KROS) Assets (2019 - 2026)
Keros Therapeutics (KROS) reported Assets of $287.6 million for Q2 2026, down 62.0% from $757.17 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Keros Therapeutics posted Assets of $338.02 million, down 45.1% from FY2024.
- Assets has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- By year, Assets came in at $615.89 million in FY2024 (+66.4%), $370.03 million in FY2023 (+20.6%), $306.78 million in FY2022 (+20.2%) and $255.25 million in FY2021 (-5.3%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q3 2022.
- Year over year, Assets gained in five of the last seven quarters, with growth averaging 27.6%.
- The high point for year-over-year Assets in five years was Q3 2024 (growth of 77.6%); the low point was Q2 2026 (a decline of 62.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Keros Therapeutics | 221.17 Mn | -1.71 Bn | - | 287.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 287.60 Mn |
| Dec 31, 2025 | 338.02 Mn |
| Sep 30, 2025 | 742.78 Mn |
| Jun 30, 2025 | 757.17 Mn |
| Mar 31, 2025 | 784.56 Mn |
| Dec 31, 2024 | 615.89 Mn |
| Sep 30, 2024 | 579.27 Mn |
| Jun 30, 2024 | 455.02 Mn |
| Mar 31, 2024 | 485.82 Mn |
| Dec 31, 2023 | 370.03 Mn |
| Sep 30, 2023 | 326.25 Mn |
| Jun 30, 2023 | 356.31 Mn |
| Mar 31, 2023 | 384.44 Mn |
| Dec 31, 2022 | 306.78 Mn |
| Sep 30, 2022 | 252.55 Mn |
| Jun 30, 2022 | 226.66 Mn |
| Mar 31, 2022 | 235.14 Mn |
| Dec 31, 2021 | 255.25 Mn |
| Sep 30, 2021 | 229.96 Mn |
| Jun 30, 2021 | 243.46 Mn |
API Access
Keros Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();